Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Mahaffey

Showing results (61-70 of 627) with videos related to

Pageof 63
Sort By:
Journal of Diabetes and Its Complications|September 11, 2007
Baseline glucose and left ventricular remodeling after acute myocardial infarctionJosé C Nicolau, Lilia N Maia, João V Vitola, et al.
Current Cardiology Reports|November 24, 2011
Promise of factor Xa inhibition in atrial fibrillationSana M Al-Khatib, John H Alexander, Renato D Lopes, et al.
Diabetes Research and Clinical Practice|April 1, 2018
Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular disease, death and safety outcomes in type 2 diabetes - A systematic reviewKarin Rådholm, Jason Hy Wu, Muh Geot Wong, et al.
Diabetes, Obesity & Metabolism|November 16, 2019
Clinical outcomes with canagliflozin according to baseline body mass index: results from post hoc analyses of the CANVAS ProgramToshiaki Ohkuma, Luc Van Gaal, Wayne Shaw, et al.
Current Controlled Trials in Cardiovascular Medicine|August 24, 2005
Enzyme estimates of infarct size correlate with functional and clinical outcomes in the setting of ST-segment elevation myocardial infarctionAslan T Turer, Kenneth W Mahaffey, Dianne Gallup, et al.
Journal of the American Geriatrics Society|March 19, 2025
The Efficacy and Safety of Canagliflozin by Frailty Status in Participants of the CANVAS and CREDENCE TrialsTu N Nguyen, Jie Yu, Vlado Perkovic, et al.
JAMA Network Open|April 30, 2024
Accuracy of Event Rate and Effect Size Estimation in Major Cardiovascular Trials: A Systematic ReviewChristoph B Olivier, Lasse Struß, Nathalie Sünnen, et al.
Annals of the American Thoracic Society|January 25, 2021
The ARREST Pneumonia Clinical Trial. Rationale and DesignJoseph E Levitt, Emir Festic, Manisha Desai, et al.
Journal of Translational Medicine|December 5, 2018
Reviewing the role of healthy volunteer studies in drug developmentJoyson J Karakunnel, Nam Bui, Latha Palaniappan, et al.
Diabetes, Obesity & Metabolism|July 22, 2020
Effects of canagliflozin on initiation of insulin and other antihyperglycaemic agents in the CANVAS ProgramDavid R Matthews, Carol Wysham, Melanie Davies, et al.
Pageof 63

Showing results (61-70 of 627) with videos related to

Sort By:
Pageof 63
Journal of Diabetes and Its Complications|September 11, 2007
Baseline glucose and left ventricular remodeling after acute myocardial infarctionJosé C Nicolau, Lilia N Maia, João V Vitola, et al.
Current Cardiology Reports|November 24, 2011
Promise of factor Xa inhibition in atrial fibrillationSana M Al-Khatib, John H Alexander, Renato D Lopes, et al.
Diabetes Research and Clinical Practice|April 1, 2018
Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular disease, death and safety outcomes in type 2 diabetes - A systematic reviewKarin Rådholm, Jason Hy Wu, Muh Geot Wong, et al.
Diabetes, Obesity & Metabolism|November 16, 2019
Clinical outcomes with canagliflozin according to baseline body mass index: results from post hoc analyses of the CANVAS ProgramToshiaki Ohkuma, Luc Van Gaal, Wayne Shaw, et al.
Current Controlled Trials in Cardiovascular Medicine|August 24, 2005
Enzyme estimates of infarct size correlate with functional and clinical outcomes in the setting of ST-segment elevation myocardial infarctionAslan T Turer, Kenneth W Mahaffey, Dianne Gallup, et al.
Journal of the American Geriatrics Society|March 19, 2025
The Efficacy and Safety of Canagliflozin by Frailty Status in Participants of the CANVAS and CREDENCE TrialsTu N Nguyen, Jie Yu, Vlado Perkovic, et al.
JAMA Network Open|April 30, 2024
Accuracy of Event Rate and Effect Size Estimation in Major Cardiovascular Trials: A Systematic ReviewChristoph B Olivier, Lasse Struß, Nathalie Sünnen, et al.
Annals of the American Thoracic Society|January 25, 2021
The ARREST Pneumonia Clinical Trial. Rationale and DesignJoseph E Levitt, Emir Festic, Manisha Desai, et al.
Journal of Translational Medicine|December 5, 2018
Reviewing the role of healthy volunteer studies in drug developmentJoyson J Karakunnel, Nam Bui, Latha Palaniappan, et al.
Diabetes, Obesity & Metabolism|July 22, 2020
Effects of canagliflozin on initiation of insulin and other antihyperglycaemic agents in the CANVAS ProgramDavid R Matthews, Carol Wysham, Melanie Davies, et al.
Pageof 63